Background & aims Inflammation plays a key role in tumor development and progression.
Vitamin D has potential tumor suppressing effects through modulation of inflammatory …

Significant advancements have been made in cancer therapy; however, limitations remain
with some conventional approaches. Adjuvants are agents used alongside primary …

Breast cancer is the second most common type of cancer in the world. Polyphenols can act
at all stages of carcinogenesis and oxyresveratrol (OXY) promising anticancer properties …

Background/Objectives: Advancements in breast cancer therapeutics, such as
anthracyclines, are improving cancer survival rates but can have side effects that limit their …

Background: The predictive role of vitamin D (VD) in breast cancer (BC) patients' survival is
still being investigated. This paper aims to evaluate the changes in VD metabolites during …

Objectives In observational studies, older adults with low serum vitamin D levels are at
higher risk of cardiovascular disease (CVD), but randomized trials have failed to …

Cisplatin (CP) is a chemotherapy drug used in a broad spectrum of cancer. The current
study investigated the protective effect of vitamin D3 (vit-D3) on CP-induced cardiotoxicity …

Purpose Anthracycline-induced cardiotoxicity (AIC) is a significant complication in cancer
treatment, impacting long-term health outcomes. This study aimed to evaluate interventional …

AIM: We aimed to investigate the possible cardioprotective effects of paricalcitol (PR), its
vitamin D receptor agonist, and vitamin D³3 (VIT-D3) on an experimental model of …

Background: Biological evidence has revealed antitumor effect of vitamin D, but whether it
could predict the response to neoadjuvant chemotherapy (NAC) in breast cancer (BC) …